OPDIVO
Live / Registered — Registered and renewed (as of 27 Mar 2026)
What this means for you
Registered since 08 Mar 2016. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 08 Mar 2026).
Record
- Serial number
- 86174642
- Registration number
- 4914296
- Mark type
- Design + words
- Filed
- 24 Jan 2014
- Published for opposition
- 02 Dec 2014
- Registered
- 08 Mar 2016
- Next maintenance due
- 08 Mar 2026
- Attorney of record
- Marilyn F. Kelly
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use for the treatment and prevention of [ obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, ] cancer [, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies ]
Owner
- Bristol-Myers Squibb Company, Princeton, NJ, US
- Bristol-Myers Squibb Company, New York, NY, US
- Bristol-Myers Squibb Company, New York, NY, US
Prosecution history
- 27 Mar 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 27 Mar 2026 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 27 Mar 2026 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 27 Mar 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 15 Jan 2026 — TEAS SECTION 8 & 9 RECEIVED
- 08 Mar 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 02 Aug 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 02 Aug 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 02 Aug 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 02 Aug 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 02 Aug 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 19 Aug 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 19 Aug 2022 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 19 Aug 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 28 Feb 2022 — TEAS SECTION 8 & 15 RECEIVED